Begin people with moderate hepatic impairment on 25% on the hydromorphone hydrochloride prolonged-launch tablets dose that would be prescribed for clients with regular hepatic operate. Carefully monitor clients with average hepatic impairment for respiratory and central anxious system melancholy during initiation of therapy with hydromorphone hydro